Literature DB >> 6833403

Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle.

E Rapaport.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833403     DOI: 10.1002/jcp.1041140305

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


× No keyword cloud information.
  30 in total

1.  Discovery of purinergic signalling, the initial resistance and current explosion of interest.

Authors:  G Burnstock
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 2.  Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

Authors:  Daniela F Passos; Maria Rosa C Schetinger; Daniela Br Leal
Journal:  World J Virol       Date:  2015-08-12

3.  Polyamine depletion increases cellular ribonucleotide levels.

Authors:  S M Oredsson; M Kanje; P S Mamont; J Wagner; O Heby
Journal:  Mol Cell Biochem       Date:  1986-04       Impact factor: 3.396

Review 4.  The biology of radioresistance: similarities, differences and interactions with drug resistance.

Authors:  S N Powell; E H Abraham
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.

Authors:  Eliezer Rapaport; Anna Salikhova; Edward H Abraham
Journal:  Purinergic Signal       Date:  2015-04-29       Impact factor: 3.765

7.  99mTc-labeled nucleotides as tumor-seeking radiodiagnostic agents.

Authors:  D R Elmaleh; P C Zamecnik; F P Castronovo; H W Strauss; E Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 8.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

9.  Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

Authors:  E Rapaport; J Fontaine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.

Authors:  W G Fang; F Pirnia; Y J Bang; C E Myers; J B Trepel
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.